114
Views
14
CrossRef citations to date
0
Altmetric
Letter to the Editor

Cardiac Toxicity During Rituximab Administration

, , &
Pages 203-204 | Published online: 03 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Shawn Shetty & A. R. Ahmed. (2013) Preliminary analysis of mortality associated with rituximab use in autoimmune diseases. Autoimmunity 46:8, pages 487-496.
Read now

Articles from other publishers (13)

VaibhavBansidhar Patil, SnehalBalvant Lunge & BhavanaRavindra Doshi. (2020) Cardiac side effect of rituximab. Indian Journal of Drugs in Dermatology 6:1, pages 49.
Crossref
Wisit Cheungpasitporn, Stephen L. Kopecky, Ulrich Specks, Kharmen Bharucha & Fernando C. Fervenza. (2016) Non-ischemic cardiomyopathy after rituximab treatment for membranous nephropathy. Journal of Renal Injury Prevention 6:1, pages 18-25.
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs 214 221 .
A. Razzaque Ahmed & Shawn Shetty. (2015) The Emerging Role of Rituximab in Autoimmune Blistering Diseases. American Journal of Clinical Dermatology 16:3, pages 167-177.
Crossref
Philip S. Macklin, Peter J. Morris & Simon R. Knight. (2015) A systematic review of the use of rituximab as induction therapy in renal transplantation. Transplantation Reviews 29:2, pages 103-108.
Crossref
Shawn Shetty, Mark C Fisher & A Razzaque Ahmed. (2016) Review on the Influence of Protocol Design on Clinical Outcomes in Rheumatoid Arthritis Treated with Rituximab. Annals of Pharmacotherapy 47:3, pages 311-323.
Crossref
Labib R. Zakka, Shawn S. Shetty & A. Razzaque Ahmed. (2012) Rituximab in the Treatment of Pemphigus Vulgaris. Dermatology and Therapy 2:1.
Crossref
Linda Lee & Vishal Kukreti. (2012) Rituximab-Induced Coronary Vasospasm. Case Reports in Hematology 2012, pages 1-3.
Crossref
M. Couderc, J.-E. Gottenberg, X. Mariette, E. Hachulla, J. Sibilia, O. Fain, A. Hot, M. Dougados, L. Euller-Ziegler, P. Bourgeois, C. Larroche, A. Tournadre, Z. Amoura, B. Mazieres, P. Arlet, M. De Bandt, T. Schaeverbeke & M. Soubrier. (2011) Efficacy and safety of rituximab in the treatment of refractory inflammatory myopathies in adults: results from the AIR registry. Rheumatology 50:12, pages 2283-2289.
Crossref
. 2009. MeylerâÂÂs Side Effects of Cardiovascular Drugs. MeylerâÂÂs Side Effects of Cardiovascular Drugs 557 820 .
Saadettin Kilickap, Bunyamin Yavuz, Sercan Aksoy, Levent Sahiner, Murat Dincer, Hakan Harputluoglu, Mustafa Erman, Kudret Aytemir, Lale Tokgozoglu & Ibrahim Barista. (2008) Addition of rituximab to chop does not increase the risk of cardiotoxicity in patients with non-Hodgkin’s lymphoma. Medical Oncology 25:4, pages 437-442.
Crossref
Thierry Vial, Jacques Descotes, Felix Braun & Matthias Behrend. 2007. 383 423 .
. (2004) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 13:3.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.